D.E. Shaw & Co
ACHC icon

D.E. Shaw & Co’s Acadia Healthcare ACHC Stock Holding History

D.E. Shaw & Co’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Sell
94,721
-973,443
-91% -$17.6M ﹤0.01% 2839
2025
Q4 		$15.2M Sell
1,068,164
-1,130,925
-51% -$21.4M 0.01% 1429
2025
Q3 		$54.4M Buy
2,199,089
+571,283
+35% +$12.7M 0.03% 614
2025
Q2 		$36.9M Buy
1,627,806
+563,945
+53% +$13.4M 0.03% 710
2025
Q1 		$32.3M Buy
1,063,861
+520,515
+96% +$19.8M 0.03% 683
2024
Q4 		$21.5M Buy
543,346
+453,093
+502% +$20.4M 0.02% 993
2024
Q3 		$5.72M Buy
90,253
+57,495
+176% +$4.15M ﹤0.01% 1838
2024
Q2 		$2.21M Sell
32,758
-106,988
-77% -$7.47M ﹤0.01% 2570
2024
Q1 		$11.1M Buy
139,746
+7,733
+6% +$632K 0.01% 1291
2023
Q4 		$10.3M Buy
132,013
+29,423
+29% +$2.18M 0.01% 1340
2023
Q3 		$7.21M Sell
102,590
-16,083
-14% -$1.2M 0.01% 1509
2023
Q2 		$9.45M Buy
118,673
+46,761
+65% +$3.38M 0.01% 1386
2023
Q1 		$5.2M Buy
71,912
+45,782
+175% +$3.57M 0.01% 1910
2022
Q4 		$2.15M Buy
26,130
+11,181
+75% +$922K ﹤0.01% 2882
2022
Q3 		$1.17M Buy
14,949
+5,965
+66% +$477K ﹤0.01% 3479
2022
Q2 		$608K Sell
8,984
-99,059
-92% -$6.91M ﹤0.01% 3986
2022
Q1 		$7.08M Buy
108,043
+96,202
+812% +$5.59M 0.01% 1941
2021
Q4 		$719K Buy
+11,841
New +$706K ﹤0.01% 4169
2021
Q3 		– Sell
-16,003
Closed -$1M – 4924
2021
Q2 		$1M Sell
16,003
-141,686
-90% -$8.88M ﹤0.01% 3533
2021
Q1 		$9.01M Sell
157,689
-60,278
-28% -$3.26M 0.01% 1432
2020
Q4 		$11M Buy
+217,967
New +$8.69M 0.01% 1339
2020
Q1 		– Sell
-127,024
Closed -$4.22M – 3876
2019
Q4 		$4.22M Buy
+127,024
New +$3.98M ﹤0.01% 1860
2018
Q1 		– Sell
-22,618
Closed -$738K – 3448
2017
Q4 		$738K Buy
+22,618
New +$784K ﹤0.01% 2751
2015
Q1 		– Sell
-29,513
Closed -$1.81M – 3587
2014
Q4 		$1.81M Buy
+29,513
New +$1.72M ﹤0.01% 2356
2014
Q3 		– Sell
-47,490
Closed -$2.16M – 4058
2014
Q2 		$2.16M Buy
+47,490
New +$2.09M ﹤0.01% 2244

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co's ACHC Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Acadia Healthcare (ACHC) stake by 91% in Q1 2026, selling an estimated $17.6M and leaving 94,721 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

D.E. Shaw & Co first reported a position in ACHC in Q2 2014 and has held it in 25 quarters since. The position peaked at $54.4M in Q3 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • D.E. Shaw & Co held 94,721 shares of Acadia Healthcare worth $2.22M as of Q1 2026.
  • D.E. Shaw & Co sold 973,443 Acadia Healthcare shares in Q1 2026, an estimated $17.6M.
  • Acadia Healthcare made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2839 holding.
  • D.E. Shaw & Co first reported a position in Acadia Healthcare in Q2 2014 and has held it in 25 quarters since.
  • D.E. Shaw & Co's Acadia Healthcare position peaked at $54.4M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.